Running Stocks: Wausau Paper Corp. (NYSE:WPP), The Walt Disney Company (NYSE:DIS), Flexion Therapeutics (NASDAQ:FLXN), MYOS Corporation (NASDAQ:MYOS)

Sirius XM Holdings Inc. (NASDAQ:SIRI) caters to the Services space. It has a net profit margin of 11.60% and weekly performance is -0.99%. On the last day of trading company shares ended up at $4.02. Sirius XM Holdings Inc. (NASDAQ:SIRI) distance from 50-day simple moving average (SMA50) is -13.20%.

On 9 December, Sirius XM Holdings Inc. (NASDAQ:SIRI) has unveiled a slate of extensive programming to celebrate FRANK SINATRA’s 100th birthday on his exclusive channel, SIRIUSLY SINATRA. The schedule will include a new special hosted by NANCY SINATRA including some of her personal favorites; shows hosted by FRANK SINATRA, JR.

Wausau Paper Corp. (NYSE:WPP) ended the last trading day at $10.21. Company weekly volatility is calculated as 0.43% and price to cash ratio as 182.61. Wausau Paper Corp. (NYSE:WPP) showed a weekly performance of -0.20%.

Wausau Paper Corp. (NYSE:WPP) declared a dividend. Investors of record on Tuesday, December 15th will be paid a dividend of 0.03 per share on Tuesday, December 22nd. The ex-dividend date of this dividend is Friday, December 11th.

The Walt Disney Company (NYSE:DIS) shares fell -1.56% in last trading session and ended the day at $112.01. DIS Gross Margin is 45.90% and its has a return on assets of 9.60%. The Walt Disney Company (NYSE:DIS) quarterly performance is 9.61%.

On 8 December, The Walt Disney Company (NYSE:DIS) has doubled its stake in Vice Media to $400 million and now owns about 10% of the edgy media company, according a person with knowledge of the matter.

Flexion Therapeutics, Inc. (NASDAQ:FLXN) shares moved down -6.94% in last trading session and ended the day at $19.31. FLXN has a return on assets of -28.80%. Flexion Therapeutics, Inc. (NASDAQ:FLXN) quarterly performance is -22.73%.

RBC Capital reissued their outperform rating on shares of Flexion Therapeutics, Inc. (NASDAQ:FLXN) in a research note released on Sunday morning,AnalystRatingsNetwork.com reports. RBC Capital currently has a $44.00 price target on the specialty pharmaceutical company’s stock.

MYOS Corporation (NASDAQ:MYOS) caters to the Healthcare space. Its weekly performance is 58.58%. On the last day of trading company shares ended up at $2.68. MYOS Corporation (NASDAQ:MYOS) distance from 50-day simple moving average (SMA50) is -1.19%.

MYOS Corporation (NASDAQ:MYOS) announced that it has entered into a securities purchase agreement with RENS Technology Inc. (the “Investor”), a wholly-owned subsidiary of RENS Agriculture Science & Technology Co. Ltd (“RENS Agriculture”), pursuant to which the Investor will invest up to $30,375,000.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *